What Semaglutide S10 actually is

The 10mg vial is our mid-concentration semaglutide formulation, used through the titration phase as patients move from starting doses toward maintenance. Same compound as the 5mg and 20mg vials — same STEP-trial pharmacology, GLP-1 receptor agonism, and weight-loss profile.¹

We move patients to the 10mg concentration when their dose exceeds what the 5mg vial conveniently delivers. Tolerability is the rate-limiting step: titrate slowly, allow GI adaptation, and watch for sustained weight loss alongside dose stability.

At Luxbae, Semaglutide S10 is prescribed and supervised by Dr. Ernst von Schwarz, MD, PhD after a complimentary medical consultation.

Mechanism — Same mechanism, different concentration

GLP-1 receptor agonism in hypothalamus and gut; slowed gastric emptying; central appetite reduction.²

What the research shows

Continued weight loss. Maintenance of weight-loss trajectory through titration.

A1C improvement. Glycemic benefit accumulates through titration.

Cardiovascular protection. SELECT-trial benefit applies once steady-state dose reached.³

Side effects: Same as 5mg — nausea, constipation, vomiting (titration-phase), fatigue. Typically diminishes with dose stability.

FDA note: Compounded under shortage rules from licensed pharmacies; brand-name semaglutide (Wegovy/Ozempic) is FDA-approved.

Semaglutide S10 FAQ

Why 10mg vial?
Mid-titration concentration. We use it when 5mg dose math becomes inconvenient and before 20mg maintenance.

How long at this concentration?
Often 1–3 months during titration.

References

1. Wilding JPH, et al. Once-Weekly Semaglutide STEP-1. N Engl J Med. 2021;384(11):989-1002.
2. Drucker DJ. Mechanisms of GLP-1. Cell Metab. 2018;27(4):740-756.
3. Lincoff AM, et al. Semaglutide SELECT. N Engl J Med. 2023;389(24):2221-2232.